Please provide your email address to receive an email when new articles are posted on . Carl Zeiss Meditec and Precise Bio have partnered to develop and commercialize fabricated corneal tissue for ...
GREENSBORO, N.C., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Precise Bio, Inc. (“Precise Bio” or the “Company”), a clinical-stage regenerative medicine company pioneering bio-printed tissues and organs with an ...
Carl Zeiss Meditec will invest in Precise Bio and fund the further development of Precise Bio's two cornea transplant products and has exclusive worldwide commercialization rights for these products ...
Ophthalmic and microsurgery device maker Carl Zeiss Meditec AG is investing in regenerative medicine startup Precise Bio Ltd. to jointly develop 4D bio-fabricated corneal transplants for diseases that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback